Amy Garabedian
General Counsel presso LAVA THERAPEUTICS N.V.
Patrimonio netto: 224 772 $ in data 31/03/2024
Posizioni attive di Amy Garabedian
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| LAVA THERAPEUTICS N.V. | General Counsel | 27/07/2021 | - |
| Corporate Secretary | 27/07/2021 | - |
Storia della carriera di Amy Garabedian
Precedenti posizioni note di Amy Garabedian
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | 01/09/2015 | 01/05/2020 |
Ballard Spahr LLP
 Ballard Spahr LLP Miscellaneous Commercial ServicesCommercial Services Ballard Spahr LLP provides legal services. It also provides counsel in litigation, business and finance, real estate, intellectual property, and public finance. The company was founded in 1885 and is headquartered in Philadelphia, PA. | General Counsel | - | - |
Formazione di Amy Garabedian
| Temple University (Pennsylvania) | Graduate Degree |
| The Pennsylvania State University | Undergraduate Degree |
| Widener University Delaware Law School | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| Paesi Bassi | 2 |
Posizioni
| General Counsel | 2 |
| Graduate Degree | 2 |
| Corporate Secretary | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| LAVA THERAPEUTICS N.V. | Health Technology |
| Aziende private | 2 |
|---|---|
Ballard Spahr LLP
Ballard Spahr LLP Miscellaneous Commercial ServicesCommercial Services Ballard Spahr LLP provides legal services. It also provides counsel in litigation, business and finance, real estate, intellectual property, and public finance. The company was founded in 1885 and is headquartered in Philadelphia, PA. | Commercial Services |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
- Borsa valori
- Insiders
- Amy Garabedian
- Esperienza
